Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 42, Issue 6, 2001, Pages 1315-1321

  Heintel, Daniel ^a   Schwarzinger, Ilse ^b   Chizzali Bonfadin, Claudia ^a   Thalhammer, Renate ^b   Schwarzmeier, Josef ^a   Fritzer Szekeres, Monika ^b   Weltermann, Ansgar ^a   Simonitsch, Ingrid ^b   Lechner, Klaus ^a   Jaeger, Ulrich ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Binet A; CD38; CLL; Prognostic factors

Indexed keywords

BETA 2 MICROGLOBULIN; CD19 ANTIGEN; CD23 ANTIGEN; CD38 ANTIGEN; TUMOR MARKER;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENDER; HUMAN; IMMUNOGLOBULIN DEFICIENCY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RELIABILITY;

ADP-RIBOSYL CYCLASE; AGED; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NAD+ NUCLEOSIDASE; NEOPLASM STAGING; PROGNOSIS;

EID: 18244394854     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190127505     Document Type: Article

References (26)

1. "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis"
2. "Prognostic factors in chronic lymphocytic leukemia"
3. "Cytogenetics in chronic lymphocytic leukemia"
4. "Advances in the treatment of chronic lymphocytic leukemia (CLL)"
5. "Progression and survival studies in early chronic lymphocytic leukemia"
6. "Clinical staging of chronic lymphocytic leukemia"
7. "Chronic lymphocytic leukemia"
8. "Chlorambucil in indolent chronic lymphocytic leukemia"
9. "Long-term follow up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent"
10. "Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukemia (CLL): A report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee EBMT Chronic Leukemias Working Party (CLWP)"
11. "Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia"
12. "Chronic lymphocytic leukemia: Staging and prognostic factors"
13. "Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta 2-microglobulin in B-cell chronic lymphocytic leukemia"
14. "Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia"
15. "Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia"
16. "Elevated serum thymidine kinase level identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia"
17. "Genomic aberrations and survival in chronic lymphocytic leukemia"
18. "Molekular cytogenetic analysis of B-cell chronic lymphocytic leukemia"
19. "Unmutated Ig V H Genes are associated with a more aggressive form of chronic lymphocytic leukemia"
20. "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia"
21. "Chronic lymphocytic leukemia: A proliferation of B cells at two distinct stages of differentiation"
22. "Lack of correlation between immunoglobulin somatic mutation and expression of CD38 in chronic lymphocytic leukemia"
23. "National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment"
24. "Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia"
25. "Immunglobulin V genes and CD38 expression in CLL"
26. "CD38 Expression is a poor predictor for VH gene mutation status and prognosis in chronic lymphocytic leukemia"